Bruneau, Julie

Principal scientist

CHUM Research Centre

Research theme

Physician
Drug addiction service, CHUM

Full professor
Department of family medicine and emergency medicine, Université de Montréal

Chairholder
Canada Research Chair in Addiction Medicine

Contact

julie.bruneau@umontreal.ca
514 890-8000, ext. 35713

The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.

Keywords

Epidemiology, HIV, HCV, injection drug use, access to medical care for drug addicts.

Research interests

Individual and contextual factors involved in the transmission of HIV and the Hepatitis C virus (HCV) among injection drug users (IDUs), with a view to identifying strategies for preventing new infections. These studies are conducted by monitoring a prospective IDU cohort seronegative for HIV and/or HCV. This cohort is linked to a geographic information system that makes it possible to study environmental and individual factors gathered during biannual meetings with participants.

Access to health care by drug addicts, in particular the evaluation of the impact of treatments for recent HCV infection among drug users on drug consumption and quality of life.

Several ongoing collaborations with researchers in epidemiology, clinical research and basic research in Quebec, Canada and abroad.

Publications

Publications indexed on PubMed

News

Covid-19 is worse for drug users: survey

r. Julie Bruneau holder of a new Canada research Chair

Injection drug use: a new study shows a mixed Canadian portrait

Dr. Julie Bruneau, one of the coauthors of The Lancet Series on Drug Use

Prevention of HCV: the dose of opioid agonist treatment matters, as does patient’s perception